Byrna Technologies Inc.
For the period ended Feb 28, 2026. Filed Apr 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Feb 28, 2026 · Filed Apr 9, 2026
BYRN$3.83+2.4%Stored close · as of Nov 6, 2026
Contents
Condensed Consolidated Statements of Cash Flows for the Three Months Ended February 28, 2026 and 2025 (unaudited)
BYRNA TECHNOLOGIES INC.
Condensed Consolidated Statements of Cash Flows
(Amounts in thousands)
| For the Three Months Ended | ||
|---|---|---|
| February 28, | ||
| 2026 | 2025 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net income for the period | $801 | $1,662 |
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Stock-based compensation expense | 535 | 840 |
| Depreciation and amortization | 635 | 440 |
| Operating lease costs | 163 | 234 |
| Deferred tax provision (asset) | 144 | 369 |
| Allowance for expected credit losses | 360 | — |
| Recovery of allowance for inventory | (76) | — |
| Changes in assets and liabilities: | ||
| Accounts receivable | (856) | (270) |
| Deferred revenue | (54) | (1,315) |
| Inventory | (329) | (3,210) |
| Prepaid expenses and other current assets | (401) | (460) |
| Other assets | (81) | (40) |
| Accounts payable and accrued liabilities | (5,089) | (1,925) |
| Operating lease liabilities | (176) | (102) |
| NET CASH USED IN OPERATING ACTIVITIES | (4,424) | (3,777) |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Purchases of property and equipment | (621) | (2,642) |
| Purchases of marketable debt securities | — | (2,656) |
| NET CASH USED IN INVESTING ACTIVITIES | (621) | (5,298) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Proceeds from stock option exercises | — | 93 |
| Repurchase of common stock | (953) | — |
| Payment of taxes withheld on issuance of restricted stock units | (7) | (67) |
| NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES | (960) | 26 |
| Effects of foreign currency exchange rate changes | 130 | (111) |
| NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH FOR THE PERIOD | (5,875) | (9,160) |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD | 13,727 | 16,829 |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD | $7,852 | $7,669 |
| Reconciliation of cash, cash equivalents and restricted cash: | ||
| Cash and cash equivalents, end of period | $7,452 | $7,669 |
| Restricted cash, end of period | 400 | — |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD | $7,852 | $7,669 |
Condensed Consolidated Statements of Changes in Stockholders’** Equity**
For the Three Months Ended February 28, 2026 and 2025
(Amounts in thousands except share numbers)
| Additional · Treasury · Accumulated Other | ||||||||
|---|---|---|---|---|---|---|---|---|
| Common Stock · Paid-in · Stock · Accumulated · Comprehensive | ||||||||
| Shares | $ | Capital | Shares | $ | Deficit | Loss | Total | |
| Balance, November 30, 2025 | 25,258,393 | $25 | $135,870 | (2,579,678) | $(22,355) | $(47,096) | $(687) | $65,757 |
| Stock-based compensation | — | — | 535 | — | — | — | — | 535 |
| Issuance of common stock pursuant to vesting of restricted stock units | 64,530 | — | (7) | — | — | — | — | (7) |
| Repurchase of common shares under StockBuyback Plan | — | — | — | (58,905) | (953) | — | — | (953) |
| Net income | — | — | — | — | — | 801 | — | 801 |
| Unrealized gain on marketable securities | — | — | — | — | — | — | 1 | 1 |
| Foreign currency translation | — | — | — | — | — | — | 354 | 354 |
| Balance, February 28, 2026 | 25,322,923 | $25 | $136,398 | (2,638,583) | $(23,308) | $(46,295) | $(332) | $66,488 |
| Balance, November 30, 2024 | 25,010,976 | $25 | $133,029 | (2,515,217) | $(21,253) | $(56,783) | $(649) | $54,369 |
| Stock-based compensation | — | — | 840 | — | — | — | — | 840 |
| Issuance of common stock pursuant to exercise of stock options | 74,551 | — | 93 | — | — | — | — | 93 |
| Issuance of common stock pursuant to vesting of restricted stock units | 96,925 | — | (67) | — | — | — | — | (67) |
| Net income | — | — | — | — | — | 1,662 | — | 1,662 |
| Unrealized gain on marketable securities | — | — | — | — | — | — | 60 | 60 |
| Foreign currency translation | — | — | — | — | — | — | (130) | (130) |
| Balance, February 28, 2025 | 25,182,452 | $25 | $133,895 | (2,515,217) | $(21,253) | $(55,121) | $(719) | $56,827 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.